Acquisition of Parenteral Solutions for the Women's Hospital Dr. Percy Boland R. Sdsdh.

BoliviaTenders notice for Acquisition of Parenteral Solutions for the Women's Hospital Dr. Percy Boland R. Sdsdh.. The reference ID of the tender is 107862365 and it is closing on 02 Oct 2024.

100% Secure Payments

Tender Details

  • Country: Bolivia
  • Summary: Acquisition of Parenteral Solutions for the Women's Hospital Dr. Percy Boland R. Sdsdh.
  • BOT Ref No: 107862365
  • Deadline: 02 Oct 2024
  • Competition: ICB
  • Financier: Self Financed
  • Purchaser Ownership: Public
  • Tender Value: Refer Document
  • Notice Type: Tender
  • Document Ref. No.: 24-0907-00-1481381-1-1
  • Purchaser's Detail :
  • Purchaser : AUTONOMOUS DEPARTMENTAL GOVERNMENT OF SANTA CRUZ
    Rodrigo Suarez Rodas (Phone 36363003-3332760 3636256)

  • Description :
  • Bidders are invited for Procurement of parenteral solutions for the women's hospital dr. percy boland r. sdsdh.
    Status: Current
    Entity: Departmental Autonomous Government of Santa Cruz
    Department: Santa Cruz
    Publication date: September 27, 2024
    Modality: CNC
  • Documents :
  •  Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN
BoliviaTenders Features

BoliviaTenders Features

Fresh and verified Tenders from Bolivia. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • Accurate Tender Information
  • New Tenders Every Day
  • Consultants for RFI/RFP/RFQ
  • Search, sort, and filter Tenders
  • Customer Support
  • Publish your Tenders
  • Consulting Services
  • Export data to Excel or CRM

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting ZimbabweTenders !!
Email Id is already exist !!
Invalid Captcha !

Get FREE SAMPLE TENDERS from Bolivia in your email inbox.

  Chat with us